Blood Transfusion, AutologousBlood TransfusionErythrocyte TransfusionTranexamic AcidBlood Loss, SurgicalHemostasis, SurgicalAntifibrinolytic AgentsCardiac Surgical ProceduresHemoglobinsPlatelet TransfusionTransplantation, HomologousExchange Transfusion, Whole BloodBlood Component TransfusionBlood Transfusion, IntrauterineBone Marrow TransplantationFetofetal TransfusionGraft vs Host DiseaseHematopoietic Stem Cell TransplantationLeukocyte TransfusionTransplantation ConditioningBlood Grouping and CrossmatchingBlood DonorsBlood BanksIsoantigensBlood Group IncompatibilityBlood PreservationHematologic NeoplasmsTreatment OutcomeIsoantibodiesLymphocyte Culture Test, MixedTransplantation ChimeraGraft SurvivalOperative Blood SalvageRetrospective StudiesAnemiaT-LymphocytesGraft vs Tumor EffectAnemia, NeonatalErythroblastosis, FetalLeukemiaHistocompatibility TestingTissue DonorsPlateletpheresisPostoperative HemorrhageSkin TransplantationTransplantation, IsogeneicWhole-Body IrradiationTime FactorsStem Cell TransplantationGraft vs Leukemia EffectHistocompatibilityAnemia, AplasticGraft vs Host ReactionTransplantation, AutologousGraft RejectionRecurrenceTransplantation ImmunologyIntraoperative CareBusulfanLymphocyte ActivationMyelodysplastic SyndromesHLA AntigensThrombocytopeniaMice, Inbred C57BLBlood SubstitutesMice, Inbred BALB CBlood SafetyImmunosuppressive AgentsPlatelet CountSpleenLeukemia, Myeloid, AcuteImmunosuppressionCytotoxicity, ImmunologicAcute DiseaseFetomaternal TransfusionRemission InductionLymphocyte DepletionHemodilutionProspective StudiesHemorrhageAnemia, Sickle CellRh IsoimmunizationImmune ToleranceHemostaticsLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMyeloablative AgonistsPeripheral Blood Stem Cell TransplantationRadiation ChimeraLeukocyte Reduction ProceduresFetoscopyVidarabineChimerismErythropoietinSurvival AnalysisRisk FactorsPrecursor Cell Lymphoblastic Leukemia-LymphomaTransplantation ToleranceLymphocytesbeta-ThalassemiaDendritic Cells